Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2626 AL 2640

Concerns regarding the inclusion of a preprint in a meta-analysis on GLP-1 agonists in Parkinson's Disease

Aubignat M.

Parkinsonism Relat Disord. 2025 Jun;135:107798. doi: 10.1016/j.parkreldis.2025.107798. Epub 2025 Mar 19.

The effects of stretching in Parkinson's disease: A systematic review of randomized controlled trials

Duñabeitia I, González-Devesa D, Blanco-Martínez N, Ayán-Pérez C.

Parkinsonism Relat Disord. 2025 May;134:107796. doi: 10.1016/j.parkreldis.2025.107796. Epub 2025 Mar 19.

Deep brain stimulation in progressive supranuclear palsy: a dead-end story? A narrative review

Bellini G, Di Rauso G, Fontanelli L, Benevento E, Becattini L, Frosini D, Ceravolo R, Del Prete E.

J Neural Transm (Vienna). 2025 Aug;132(8):1095-1111. doi: 10.1007/s00702-025-02904-4. Epub 2025 Mar 24.

The role of nuclear medicine in neurodegenerative diseases: a narrative review

Riahi F, Fesharaki S.

Am J Neurodegener Dis. 2025 Feb 25;14(1):34-41. doi: 10.62347/SOGE3962. eCollection 2025.

Impact of Whole-Body Vibration Therapy in Elderly Populations: A Scoping Review

Alfieri GR, Eaton AC, Dourvetakis K, Rigueros M, Creamean T, Mayrovitz HN.

Cureus. 2025 Feb 19;17(2):e79296. doi: 10.7759/cureus.79296. eCollection 2025 Feb.

Cerebrospinal Fluid Biomarkers for Diagnosis of Parkinson's disease: A Systematic Review

Dasari M, Medapati RV.

Cureus. 2025 Feb 20;17(2):e79386. doi: 10.7759/cureus.79386. eCollection 2025 Feb.

Future applications of fluorescence lifetime imaging ophthalmoscopy in neuro-ophthalmology, neurology, and neurodegenerative conditions

Markowitz DM, Affel E, Hajnóczky G, Sergott RC.

Front Neurol. 2025 Mar 7;16:1493876. doi: 10.3389/fneur.2025.1493876. eCollection 2025.

Unconventional exercises for motor function in Parkinson's disease: an umbrella review of meta-analyses

Zhang J, Wu M, Hou X, Song W, Li J, Teng L, Li X, Yu D, Pan J, Zhu L.

Age Ageing. 2025 Mar 3;54(3):afaf062. doi: 10.1093/ageing/afaf062.

Advanced Parkinson's disease and eligibility for device-aided therapies in Morocco: a multicenter cross-sectional study

Daghi M, Serhier Z, Lakhdar A, El Otmani H.

Neurodegener Dis Manag. 2025 Apr-Jun;15(2-3):65-76. doi: 10.1080/17582024.2025.2481818. Epub 2025 Mar 24.

Recent advances in blood-brain barrier-on-a-chip models

Vetter J, Palagi I, Waisman A, Blaeser A.

Acta Biomater. 2025 May 1;197:1-28. doi: 10.1016/j.actbio.2025.03.041. Epub 2025 Mar 22.

Speech and language biomarkers for Parkinson's disease prediction, early diagnosis and progression

Cao F, Vogel AP, Gharahkhani P, Renteria ME.

NPJ Parkinsons Dis. 2025 Mar 24;11(1):57. doi: 10.1038/s41531-025-00913-4.

Immune cell metabolic dysfunction in Parkinson's disease

Mark JR, Tansey MG.

Mol Neurodegener. 2025 Mar 24;20(1):36. doi: 10.1186/s13024-025-00827-y.

Levodopa-Entacapone-Carbidopa Intrajejunal Infusion in Advanced Parkinson's Disease - Interim Analysis of the ELEGANCE Study

Weiss D, Jost WH, Szász JA, Pirtošek Z, Milanov I, Tomantschger V, Kovács N, Staines H, Amlani B, Smith N, van Laar T.

Mov Disord Clin Pract. 2025 Aug;12(8):1075-1085. doi: 10.1002/mdc3.70046. Epub 2025 Mar 25.

The effects of dynamic flamingo balance exercises and balance training with a Tetrax(®) posturography device on the balance performance and fall risk of patients with Parkinson's disease

Karagül S, Kartaloğlu IF.

J Back Musculoskelet Rehabil. 2025 Jul;38(4):766-773. doi: 10.1177/10538127251314727. Epub 2025 Mar 25.

PTEN: a new dawn in Parkinson's disease treatment

Yang X, Liu T, Cheng H.

Front Cell Neurosci. 2025 Mar 10;19:1497555. doi: 10.3389/fncel.2025.1497555. eCollection 2025.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias